This biotech stock is a bargain: Strategist By: CNBC.com News May 13, 2015 at 14:45 PM EDT Options expert Stacey Gilbert explains why Celgene is trading at a discount to its peers. Read More >> Related Stocks: Celgene Corp Nasdaq Biotechnology Ishares ETF